Recently, Liao et al. generated a dual-AAV system and showed that co-injection of AAV-Cas9 with an AAV-gRNA was capable of successfully targeting the utrophin gene in vivo, and could ameliorate muscular dystrophy symptoms in mdx mice [37]. This evidence concerns the gene UTRN and muscular dystrophy.